CAMP
CAMP4 THERAPEUTICS CORPORATION Healthcare - Biotechnology Investor Relations →
CAMP4 THERAPEUTICS CORPORATION (CAMP) closed at $3.84 as of 2026-02-02, trading 8.5% below its 200-week moving average of $4.20. This places CAMP in the deep value zone. The stock moved further from the line this week, up from -11.9% last week. The 14-week RSI sits at 48, indicating neutral momentum.
Over the past 21 weeks of data, CAMP has crossed below its 200-week moving average 3 times. On average, these episodes lasted 4 weeks.
With a market cap of $199 million, CAMP is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -172.7%. The stock trades at 3.1x book value.
Share count has increased 3.4% over three years, indicating dilution.
In the past 12 months, corporate insiders have made 7 open-market purchases totaling $15,563,424. Multiple insiders purchased within a 30-day window — a cluster buy pattern that historically signals management confidence in the company's prospects. Notably, these purchases occurred while CAMP is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Historical Touches
CAMP has crossed below its 200-week MA 3 times
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Sep 2025 | Oct 2025 | 6 | 44.9% | N/A | +68.4% |
| Nov 2025 | Dec 2025 | 3 | 28.3% | N/A | +32.4% |
| Jan 2026 | Ongoing | 3+ | 11.9% | Ongoing | -4.2% |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02